Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-003150

President sold 8,814 shares at an average $60.46 ($532,895)

  • President sold 6,186 shares at $60.44 ($373,882)
  • President acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-08 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-08 Sale : show line 2 in the form −1,657 $58.82 $97,465 13,343 D
2021-01-08 Sale : show line 3 in the form −2,213 $59.70 $132,116 11,130 D
2021-01-08 Sale : show line 4 in the form +6,186 $60.44 $373,882 4,944 D
2021-01-08 Sale : show line 5 in the form −4,944 $61.35 $303,314 0 D
Open-market sales · 15,000 sh · avg $60.45 · $906,777

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-08 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −15,000 305,000 D
Loading xslF345X03/doc4.xml…